355 related articles for article (PubMed ID: 16403712)
1. The use of minimized extracorporeal circulation system has a beneficial effect on hemostasis--a randomized clinical study.
Abdel-Rahman U; Martens S; Risteski P; Ozaslan F; Riaz M; Moritz A; Wimmer-Greinecker G
Heart Surg Forum; 2006; 9(1):E543-8. PubMed ID: 16403712
[TBL] [Abstract][Full Text] [Related]
2. Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients: selected parameters of coagulation and inflammatory system.
Wippermann J; Albes JM; Hartrumpf M; Kaluza M; Vollandt R; Bruhin R; Wahlers T
Eur J Cardiothorac Surg; 2005 Jul; 28(1):127-32. PubMed ID: 15939621
[TBL] [Abstract][Full Text] [Related]
3. Initial experience with a minimized extracorporeal bypass system: is there a clinical benefit?
Abdel-Rahman U; Ozaslan F; Risteski PS; Martens S; Moritz A; Al Daraghmeh A; Keller H; Wimmer-Greinecker G
Ann Thorac Surg; 2005 Jul; 80(1):238-43. PubMed ID: 15975373
[TBL] [Abstract][Full Text] [Related]
4. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
5. Hemostasis in off-pump compared to on-pump coronary artery bypass grafting: a prospective, randomized study.
Vedin J; Antovic A; Ericsson A; Vaage J
Ann Thorac Surg; 2005 Aug; 80(2):586-93. PubMed ID: 16039210
[TBL] [Abstract][Full Text] [Related]
6. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
[TBL] [Abstract][Full Text] [Related]
7. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting.
Nakahira A; Sasaki Y; Hirai H; Fukui T; Matsuo M; Takahashi Y; Kotani S; Suehiro S
Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):555-60. PubMed ID: 20061337
[TBL] [Abstract][Full Text] [Related]
8. Miniaturized cardiopulmonary bypass in coronary artery bypass surgery: marginal impact on inflammation and coagulation but loss of safety margins.
Nollert G; Schwabenland I; Maktav D; Kur F; Christ F; Fraunberger P; Reichart B; Vicol C
Ann Thorac Surg; 2005 Dec; 80(6):2326-32. PubMed ID: 16305899
[TBL] [Abstract][Full Text] [Related]
9. Hemostatic changes and clinical sequelae after on-pump compared with off-pump coronary artery bypass surgery: a prospective randomized study.
Paulitsch FS; Schneider D; Sobel BE; Rached R; Ramires J; Jatene F; Stolf N; Hueb W; Lopes NH
Coron Artery Dis; 2009 Mar; 20(2):100-5. PubMed ID: 19293667
[TBL] [Abstract][Full Text] [Related]
10. A biocompatible cardiopulmonary bypass strategy to reduce hemostatic and inflammatory alterations: a randomized controlled trial.
Paparella D; Scrascia G; Rotunno C; Marraudino N; Guida P; De Palo M; Rubino G; Cappabianca G
J Cardiothorac Vasc Anesth; 2012 Aug; 26(4):557-62. PubMed ID: 22658688
[TBL] [Abstract][Full Text] [Related]
11. Cardiopulmonary bypass copolymer surface modification reduces neither blood loss nor transfusions in coronary artery surgery.
Südkamp M; Mehlhorn U; Reza Raji M; Hekmat K; Easo J; Geissler HJ; Sindhu D; de Vivie R
Thorac Cardiovasc Surg; 2002 Feb; 50(1):5-10. PubMed ID: 11847596
[TBL] [Abstract][Full Text] [Related]
12. Prospective randomized study comparing coronary artery bypass grafting with the new mini-extracorporeal circulation Jostra System or with a standard cardiopulmonary bypass.
Remadi JP; Rakotoarivelo Z; Marticho P; Benamar A
Am Heart J; 2006 Jan; 151(1):198. PubMed ID: 16368318
[TBL] [Abstract][Full Text] [Related]
13. Coronary artery bypass grafting with a minimized cardiopulmonary bypass circuit: a prospective, randomized trial.
Sakwa MP; Emery RW; Shannon FL; Altshuler JM; Mitchell D; Zwada D; Holter AR
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):481-5. PubMed ID: 19185173
[TBL] [Abstract][Full Text] [Related]
14. Pulsatile perfusion with intra-aortic balloon pumping ameliorates whole body response to cardiopulmonary bypass in the elderly.
Onorati F; Santarpino G; Presta P; Caroleo S; Abdalla K; Santangelo E; Gulletta E; Fuiano G; Costanzo FS; Renzulli A
Crit Care Med; 2009 Mar; 37(3):902-11. PubMed ID: 19237895
[TBL] [Abstract][Full Text] [Related]
15. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
[TBL] [Abstract][Full Text] [Related]
16. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of using a minimal extracorporeal circulation system during coronary artery bypass grafting.
Liu Y; Tao L; Wang X; Cui H; Chen X; Ji B
Perfusion; 2012 Jan; 27(1):83-9. PubMed ID: 21987667
[TBL] [Abstract][Full Text] [Related]
18. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation.
Livingston ER; Fisher CA; Bibidakis EJ; Pathak AS; Todd BA; Furukawa S; McClurken JB; Addonizio VP; Jeevanandam V
Circulation; 1996 Nov; 94(9 Suppl):II227-34. PubMed ID: 8901751
[TBL] [Abstract][Full Text] [Related]
19. Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system.
Jensen E; Andréasson S; Bengtsson A; Berggren H; Ekroth R; Larsson LE; Ouchterlony J
Ann Thorac Surg; 2004 Mar; 77(3):962-7. PubMed ID: 14992907
[TBL] [Abstract][Full Text] [Related]
20. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
